Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. PharmaCielo Ltd.
  6. News
  7. Summary
    PCLO   CA71716K1012

PHARMACIELO LTD.

(PCLO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PharmaCielo Reports Q1 Results, Also Appoints Chief Financial Officer

05/31/2021 | 10:26am EDT


© MT Newswires 2021
All news about PHARMACIELO LTD.
09/14PHARMACIELO : Receives Confirmation of Colombian Phytotherapeutics GMP Certification
AQ
09/01PHARMACIELO : Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and ..
AQ
09/01PharmaCielo Ltd. Announces Board Appointments
CI
08/20PHARMACIELO : Says its Second-Quarter Loss Widens as Sales Plunge; CEO Departs
MT
08/20Pharmacielo Ltd. Announces CEO Changes
CI
08/20PharmaCielo Ltd. Announces Earnings Results for the Six Months Ended June 30, 2021
CI
08/20Pharmacielo Ltd. Provides Revenue Guidance for the Second Half of 2021
CI
08/20PHARMACIELO : Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO
AQ
08/20PharmaCielo Ltd. Announces Resignation of Henning Von Koss as Director
CI
08/04PHARMACIELO : Signs Sales Agreement and Makes Initial Commercial Sale to Pharmaceutical Pl..
AQ
More news
Financials
Sales 2021 4,04 M 3,19 M 3,19 M
Net income 2021 -20,5 M -16,3 M -16,3 M
Net Debt 2021 - - -
P/E ratio 2021 -9,77x
Yield 2021 -
Capitalization 189 M 149 M 149 M
Capi. / Sales 2021 46,8x
Capi. / Sales 2022 7,64x
Nbr of Employees -
Free-Float 96,9%
Chart PHARMACIELO LTD.
Duration : Period :
PharmaCielo Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMACIELO LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,27 CAD
Average target price 2,38 CAD
Spread / Average Target 87,0%
EPS Revisions
Managers and Directors
Bill Petron Chairman & Chief Executive Officer
Ian D. Atacan Chief Financial Officer
Matteo Lorenzo Pellegrini Independent Director
Douglas H. Bache Independent Director
Claudia Jimenez Jaramillo Director
Sector and Competitors
1st jan.Capi. (M$)
PHARMACIELO LTD.-38.94%149
CURALEAF HOLDINGS, INC.2.36%8 652
BEIJING TONGRENTANG CO., LTD34.56%6 711
CANOPY GROWTH CORPORATION-43.77%5 456
DONG-E-E-JIAO CO.,LTD.-9.89%3 426
CRONOS GROUP INC.-18.44%2 120